[go: up one dir, main page]

TR200000589T2 - Tümöre karşı maddeler olarak 4-amino -2(5H)-furanonların ve 4-amino-2(5H)-tiyofenonların üreido ve tiyoüreido türevleri. - Google Patents

Tümöre karşı maddeler olarak 4-amino -2(5H)-furanonların ve 4-amino-2(5H)-tiyofenonların üreido ve tiyoüreido türevleri.

Info

Publication number
TR200000589T2
TR200000589T2 TR2000/00589T TR200000589T TR200000589T2 TR 200000589 T2 TR200000589 T2 TR 200000589T2 TR 2000/00589 T TR2000/00589 T TR 2000/00589T TR 200000589 T TR200000589 T TR 200000589T TR 200000589 T2 TR200000589 T2 TR 200000589T2
Authority
TR
Turkey
Prior art keywords
amino
sulfur
oxygen
uureido
thiophenones
Prior art date
Application number
TR2000/00589T
Other languages
English (en)
Inventor
Menta Ernesto
Pescalli Nicoletta
Conti Marco
Zimmermann Gerd
Original Assignee
Roche Diagnostics Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roche Diagnostics Gmbh filed Critical Roche Diagnostics Gmbh
Publication of TR200000589T2 publication Critical patent/TR200000589T2/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/58—One oxygen atom, e.g. butenolide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/66—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30—Hetero atoms other than halogen
    • C07D333/32—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30—Hetero atoms other than halogen
    • C07D333/36—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Bu bulusun konusu, ilaçlar, özellikle tümöre karsi maddeler olarak kullanilmak üzere genel formül (I)'e sahip bilesikler, bunlarin saf stereoizomerleri veya karisimlari ve ayrica farmasötik olarak kabul edilebilir asitler veya bazlarla olusturuldugu tuzlardir; buradaki formülde, A, oksijen veya kükürttür; X, oksijen veya kükürttür; R1 ve R2, bagimsiz olarak hidrojen veya 1-6 karbon atomuna sahip bir alkil grubudur; R, alkil, sikloalkil, alkilsülfinil, alkilsülfonil, hidroksialkil, naftil, ikamesiz veya ikameli olabilen fenil grubundan seçilir; veya R, seçime bagli olarak benzo ile yogunlastirilan, oksijen, kükürt ve azottan seçilen 1-3 heteroatom içeren 5- veya 6-üyeli bir heterosikldir.
TR2000/00589T 1997-09-05 1998-09-01 Tümöre karşı maddeler olarak 4-amino -2(5H)-furanonların ve 4-amino-2(5H)-tiyofenonların üreido ve tiyoüreido türevleri. TR200000589T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP97115391 1997-09-05

Publications (1)

Publication Number Publication Date
TR200000589T2 true TR200000589T2 (tr) 2000-07-21

Family

ID=8227318

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2000/00589T TR200000589T2 (tr) 1997-09-05 1998-09-01 Tümöre karşı maddeler olarak 4-amino -2(5H)-furanonların ve 4-amino-2(5H)-tiyofenonların üreido ve tiyoüreido türevleri.

Country Status (16)

Country Link
US (2) US6333346B1 (tr)
EP (1) EP1009747A1 (tr)
JP (1) JP2001515894A (tr)
KR (1) KR20010023549A (tr)
CN (1) CN1278256A (tr)
AR (1) AR014908A1 (tr)
AU (1) AU748490B2 (tr)
BR (1) BR9812629A (tr)
CA (1) CA2302284A1 (tr)
CO (1) CO4970714A1 (tr)
HR (1) HRP980480A2 (tr)
MA (1) MA24668A1 (tr)
PE (1) PE107599A1 (tr)
TR (1) TR200000589T2 (tr)
WO (1) WO1999012917A1 (tr)
ZA (1) ZA988096B (tr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1309593B1 (it) * 1999-03-05 2002-01-24 Novuspharma Spa Composti eterociclici ad attivita' antitumorale.
KR20010094519A (ko) * 2000-03-31 2001-11-01 서경배 2,2,4,5-사중 치환된 3(2ｈ)-퓨라논 유도체의 제조 방법
GB9928696D0 (en) 1999-12-03 2000-02-02 Swan Thomas & Co Ltd Optical devices and methods of manufacture thereof
IT1315267B1 (it) 1999-12-23 2003-02-03 Novuspharma Spa Derivati di 2-(1h-indol-3-il)-2-oxo-acetammidi ad attivita'antitumorale
US20060211759A1 (en) * 2001-07-26 2006-09-21 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Bis-heterocyclic compounds with antitumour and chemosensitising activity
WO2003018575A1 (en) * 2001-08-24 2003-03-06 Wyeth Holdings Corporation 5-substituted-3(2h)-furanones useful for inhibition of farnesyl-protein transferase
CA2491802C (en) * 2002-07-09 2012-04-10 Fasgen, Inc. Novel compounds, pharmaceutical compositions containing same, and methods of use for same
KR20040018295A (ko) * 2002-08-22 2004-03-03 임철부 항암 활성을 갖는 티오우레이도 세라마이드 유도체 및 이화합물을 함유하는 약학적 조성물
KR100555655B1 (ko) * 2002-11-20 2006-03-03 임철부 항암 활성을 갖는 우레이도 또는 티오우레이도 유도체 및이 화합물을 함유하는 약학조성물
CN1301253C (zh) * 2003-07-31 2007-02-21 中国人民解放军军事医学科学院毒物药物研究所 五元硫杂环类化合物及其用于制备治疗和预防肥胖相关疾病的药物的用途
CN101161645B (zh) * 2007-11-27 2010-06-23 南京大学 尿素类衍生物及其制备方法与用途
CN101560175B (zh) * 2009-05-08 2012-10-10 南京大学 一类硫脲类衍生物及其制备方法与用途
CN106800544B (zh) * 2017-01-19 2019-09-06 华南师范大学 3-卤-4-联苯胺基-2(5h)-呋喃酮类化合物及其在制备抗肿瘤药物中的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE27894E (en) 1972-05-15 1974-01-22 Hydroxy-j-(j-phenylureido)crotonic acid, gamma lactone compounds
AR206143A1 (es) * 1974-04-17 1976-06-30 Du Pont Procedimiento para la preparacion de compuestos de 1 - t - alquil - 3 - (2,5 - dihidro - 5 - oxo - 3 - furil) ureas
SE7702004L (sv) * 1976-03-24 1977-09-25 Du Pont Antihypertensiva furylkarbamider
JPS63174983A (ja) * 1987-01-16 1988-07-19 Sumitomo Chem Co Ltd アミノブテノリド誘導体、その製造法およびそれを有効成分とする除草剤

Also Published As

Publication number Publication date
AR014908A1 (es) 2001-04-11
AU748490B2 (en) 2002-06-06
JP2001515894A (ja) 2001-09-25
CA2302284A1 (en) 1999-03-18
WO1999012917A1 (en) 1999-03-18
CN1278256A (zh) 2000-12-27
HRP980480A2 (en) 1999-06-30
PE107599A1 (es) 1999-11-03
US6333346B1 (en) 2001-12-25
CO4970714A1 (es) 2000-11-07
EP1009747A1 (en) 2000-06-21
AU9535098A (en) 1999-03-29
KR20010023549A (ko) 2001-03-26
BR9812629A (pt) 2000-08-22
MA24668A1 (fr) 1999-07-01
ZA988096B (en) 2000-03-22
US20020058694A1 (en) 2002-05-16

Similar Documents

Publication Publication Date Title
TR200000589T2 (tr) Tümöre karşı maddeler olarak 4-amino -2(5H)-furanonların ve 4-amino-2(5H)-tiyofenonların üreido ve tiyoüreido türevleri.
DE3781080D1 (de) 2-substituierte-e-kondensierte(1,2,4)triazolo-(1,5-c)pyrimidine, pharmazeutische zubereitungen und ihre verwendung.
DK0625977T3 (da) Piperazinderivater som 5-1A-antagonister
NO903914D0 (no) Fremgangsmaate ved fremstilling av heterosykliske forbindelser.
ATE275134T1 (de) 4-oxo-1,4-dihydro-3-chinolincarboxamide als antivirale mittel
DE69628645D1 (de) Benzimidazolderivaten-enthaltende pharmazeutische zusammensetzungen zur inhibierung des krebswachstums
TR199800371T1 (tr) Piperazine türevleri ve bunlarin hazirlanma prosesi.
NZ330078A (en) Active oxygen carriers containing pterin derivatives and salts thereof for use as cosmetic agents and feed
MX9707809A (es) Una composicion farmaceutica que contiene bencimidazol para inhibir el crecimiento de canceres.
NO168890C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive acylcephalosporinderivater
DE69321609D1 (de) Piperazinderivate
NO961236L (no) Pyrrolodiazin-derivater som stabilisatorer for klorholdige polymerisater
NO933477D0 (no) 6-heterosyklisk-4-amino-1,3,4,5-tetrahydrobenz(cd)indolerfor behandling av reisesyke og oppkast
ES2106439T3 (es) 5-(piperazinilalquil)-1,5-benzotiazepinonas utiles como antagonistas de calcio.
AU692334B2 (en) Thiazolidinone compounds or angina pectoris remedy or preventive containing the same as active ingredient
ES2076247T3 (es) Derivados de la pteridina farmaceuticamente eficaces.
ECSP982657A (es) Ureido y tioureido derivados de 4- amino -2(5h)-furanonas y 4- amino-2 tiofenonas como agentes antitumorales
TR199901102T2 (tr) Bisiklik amin türevleri.
IT1210914B (it) Eterociclilfenilsolfonil e fosfonilamidine sostituite, procedimento per la loro preparazione e loro uso farmaceutico.
BR9816018A (pt) Derivados de carbolina como inibidores de fosfodiesterase de cgmp